查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1364962

IVD 品質控制市場：按服務提供（產品、數據管理、服務）、按技術（生物化學、分子、免疫測定、血液學）、按應用（傳染病、腫瘤學、心臟病學）、按最終用戶- 2030 年之前的世界預測

IVD Quality Control Market by Offering (Product, Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 267 Pages | 訂單完成後即時交付

價格

IVD 品質管制市場：依產品（產品[血清、血液、尿液]、資料管理、服務）、依技術（生物化學、分子、免疫測定、血液學）、依應用（傳染病、腫瘤學）、心臟病學） ，按最終用戶 - 2030 年全球預測

IVD品質控制市場預計到2030年將達到21.9億美元，2023年至2030年的複合年增長率為4.3%。

經過廣泛的初級和二級研究，本報告對 IVD 品質控制市場進行了深入分析。 它還提供了有關 IVD 品質控制市場的關鍵驅動因素、市場限制、挑戰和機會的見解。 IVD品質控制市場的成長是由於慢性病盛行率上升、老年人口不斷增長、對第三方品質控制的需求不斷增加、對內部和外部品質評估報告的需求以及臨床品質控制的成長所推動的。實驗室的數量以及對現場護理和快速診斷的需求不斷增加。 然而，嚴格的技術要求和品質控制監管流程限制了該市場的成長。

對多項目和多分析物測試的需求不斷增長是市場成長的機會。 然而，不斷變化的監管環境和缺乏品質控制/品質保證材料是市場成長的主要挑戰。

到 2023 年，品質控制產品領域預計將佔據 IVD 品質控制市場的最大份額。 診斷產品的採用增加、對外部品質評估計劃的需求（因為這些計劃中使用了品質控制）、多分析物品質控制的開發、新產品的發布以及對獨立控制的需求增加。它貢獻了最大份額部分。

從技術角度來看，免疫分析/免疫化學領域預計將在 2023 年佔據 IVD 品質控制市場的最大份額。 慢性病和傳染病的日益普及、免疫測定/免疫化學測試的日益採用、這些測試的技術創新以及品質控制的同步發展正在為這一領域的最大份額做出貢獻。

在這些應用中，預計2023年傳染病領域將佔據IVD品質控制市場的最大份額。 由於傳染病的日益流行，可以採用廣泛的品質控制來監控肝炎、逆轉錄病毒、性傳播疾病和先天性疾病等傳染病的體外診斷藥物（IVD）檢測的測量準確性。曾經。 根據世界衛生組織統計，2020年全球報告新增性傳染感染病例3.76億例，其中衣原體病例1.29億例、淋病病例8200萬例、梅毒病例710萬例、滴蟲病估計有1.56億例。 診斷此類傳染病的需要還需要對測試品質評估進行品質控制，這進一步支持了該細分市場的最大份額。

在最終用戶中，醫院和診所預計將在 2023 年佔據 IVD 品質控制市場的最大份額。 這一巨大的細分市場份額主要是由醫院進行的大量診斷測試、醫療保健相關感染 (HAI) 患病率上升、醫療保健成本上升以及新興市場醫院和診所數量不斷增加推動的。

IVD 品質控制市場區域情境的詳細分析提供了五個主要區域（北美、歐洲、亞太地區、拉丁美洲、中東和非洲）的詳細定性和定量見解，並提供了國家覆蓋範圍。 預計到2023年，北美將佔據IVD品質控制市場的最大份額，其次是歐洲、亞太地區、拉丁美洲、中東和非洲。 慢性病和傳染病的高盛行率、疾病早期診斷意識的提高、先進診斷產品的採用增加、籌款活動增加以及診斷技術的新發展，再加上這是支持市場份額的因素。

調查範圍：

IVD 品質控制市場中產品供應的評估

  • 品質控制產品
    • 品質控制產品（依產品類型）
  • 以血清/血漿為基礎的對照
  • 基於全血
  • 基於尿液的控制
  • 其他控件
    • 依功能劃分的品質管制產品
  • 獨立控制
  • 特定於設備的控制
  • 品質評估服務
  • 資料管理解決方案

註釋其他對照組包括基於唾液的對照、基於腦脊髓液的對照和蛋白質對照。

依技術評估 IVD 品質管制市場

  • 免疫測定/免疫化學
  • 生物化學/臨床化學
  • 分子診斷
  • 血液學
  • 凝血/止血
  • 微生物學
  • 其他技術

註釋其他技術包括組織化學、尿液分析、全血糖監測等。

按應用分類的 IVD 品質控制市場評估

  • 傳染病
  • 腫瘤學
  • 心臟病學
  • 自體免疫疾病
  • 神經病學
  • 其他

Annotation 其他應用包括懷孕和不孕症檢測、藥物濫用檢測、糖尿病、遺傳疾病、微量元素檢測等。

最終用戶對 IVD 品質控制市場的評估

  • 醫院/診所
  • 診斷實驗室
  • 學術機構與研究機構
  • 其他最終用戶

注意其他最終使用者包括居家照護、療養院、門診照護中心、輸血實驗室等。

IVD品質控制市場的區域評估

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東/非洲

目錄

第一章簡介

第二章研究方法

第 3 章執行摘要

第 4 章市場洞察

  • 市場
  • 摘要
  • 影響市場成長的因素
    • 市場動態影響分析
    • 因素分析
  • 技術趨勢
  • 監理分析
    • IVD 產品法規
      • 北美
        • 美國
        • 加拿大
      • 歐洲
      • 亞太地區
        • 中國
        • 日本
        • 印度
      • 拉丁美洲
      • 中東/非洲
    • 有關品質管制的規定
      • 北美
        • 美國
        • 加拿大
      • 歐洲
        • 德國
        • 法國
        • 英國
        • 義大利
        • 西班牙
        • 其他歐洲 (RoE)
      • 亞太地區
        • 中國
        • 日本
        • 印度
        • 其他亞太地區 (RoAPAC)
      • 拉丁美洲
      • 中東/非洲
  • 價格分析
  • 波特五力分析
  • 相關市場分析：體外診斷（IVD）市場

第五章體外診斷藥物（IVD）品質管制市場：產品特定評估

  • 摘要
  • 品質控制產品
    • 品質控制產品（按類型）
      • 基於血清/血漿的控制
      • 基於全血
      • 基於尿液的控制
      • 其他控件
    • 依功能劃分的品質管制產品
      • 獨立控制
      • 特定於設備的控制
  • 品質評估服務
  • 資料管理解決方案

第六章 IVD 品質管制市場的技術評估

  • 摘要
  • 免疫測定/免疫化學
  • 生物化學/臨床化學
  • 分子診斷
  • 血液學
  • 凝血/止血
  • 微生物學
  • 其他技術

第七章 IVD 品質控制的全球市場：按應用評估

  • 摘要
  • 傳染病
  • 腫瘤學
  • 循環系統
  • 自體免疫疾病
  • 神經病學
  • 其他用途

第8章最終使用者對IVD品質管制市場的評估

  • 摘要
  • 醫院/診所
  • 診斷實驗室
  • 學術機構/研究機構
  • 其他最終用戶

第九章IVD品質管制市場區域評估

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東/非洲

第10章競爭分析

  • 簡介
  • 主要成長策略
  • 競爭基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 領先企業
    • 新興公司

第十一章公司簡介

  • Siemens Healthineers AG
    • 公司簡介
    • 財務概覽
    • 產品組合
    • SWOT分析
  • Bio-Rad Laboratories, Inc.
    • 公司簡介
    • 財務概覽
    • 產品組合
    • 策略發展
    • SWOT分析
  • Danaher Corporation
    • 公司簡介
    • 財務概覽
    • 產品組合
    • SWOT分析
  • LGC Group
    • 公司簡介
    • 財務概覽
    • 產品組合
    • 策略發展
    • SWOT分析
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 財務概覽
    • 產品組合
    • 策略發展
    • SWOT分析
  • Randox Laboratories Ltd.
    • 公司簡介
    • 產品組合
    • 策略發展
    • SWOT分析
  • SERO AS
    • 公司簡介
    • 產品組合
    • 策略發展
  • QuidelOrtho Corporation
    • 業務概覽
    • 財務概覽
    • 產品組合
    • 策略發展
  • Streck LLC
    • 公司簡介
    • 產品組合
    • 策略發展
  • Microbiologics, Inc.
    • 公司簡介
    • 產品組合
    • 策略發展
  • Bio-Techne Corporation
    • 公司簡介
    • 財務概覽
    • 產品組合
    • 策略發展

第12章附錄

Product Code: MRHC - 104119

IVD Quality Control Market by Offering (Product [Serum, Blood, Urine-based], Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User-Global Forecast to 2030

The IVD quality control market is expected to reach $2.19 billion by 2030, at a CAGR of 4.3% from 2023 to 2030.

After extensive primary and secondary research, the report provides an in-depth analysis of the IVD quality control market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the IVD quality control market. The growth of the IVD quality control market is driven by the rising prevalence of chronic diseases, coupled with the increasing geriatric population, growing demand for third-party quality controls, need for internal and external quality assessment reports, increasing number of clinical laboratories, growing demand for Point-of-Care (POC) and rapid diagnostics. However, stringent technical requirements and regulatory processes for quality controls restrain this market's growth.

The growing demand for multi-analyte and multi-instrument controls offers opportunities for market growth. However, the evolving regulatory landscape and lack of access to quality control/quality assurance materials are the major challenges to market growth.

Among the offering, in 2023, the quality control products segment is estimated to account for the largest share of the IVD quality control market. Increasing adoption of diagnostic products, demand for external quality assessment programs as these programs use quality controls in their programs, development of multi-analyte quality controls, new product launches, and increasing demand for independent controls contribute to the segments' largest share.

Among the technologies, in 2023, the immunoassay/immunochemistry segment is estimated to account for the largest share of the IVD quality control market. The growing prevalence of chronic and infectious diseases and the increased adoption of immunoassay/immunochemistry tests, technological innovations in these tests, and the simultaneous development of quality control contributed to the segment's largest share.

Among the application, in 2023, the infectious diseases segment is estimated to account for the largest share of the IVD quality control market. The increasing prevalence of infectious diseases has led to the availability of a broad range of quality controls that are designed to monitor the assay precision of IVD tests for infectious diseases such as hepatitis, retrovirus, sexually transmitted diseases, congenital diseases, and other infectious diseases. According to the WHO, in 2020, there were an estimated 376 million new cases of sexually transmitted infections (STIs) worldwide, with chlamydia accounting for 129 million, gonorrhea for 82 million, syphilis for 7.1 million, and trichomoniasis for 156 million of the reported cases. The need for diagnosis of such infectious diseases also required quality controls for the quality assessment of tests, which further supported the largest share of the segment.

Among the end users, in 2023, the hospitals & clinics segment is estimated to account for the largest share of the IVD quality control market. The large segment share is majorly attributed to the large volume of diagnostics tests carried out in the hospitals, the rising prevalence of healthcare-associated infections (HAIs), increasing healthcare expenditure, and the rising number of hospitals and clinics across emerging markets.

An in-depth analysis of the geographical scenario of the IVD quality control market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the IVD quality control market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The high prevalence of chronic and infectious diseases, increasing awareness regarding early disease diagnosis, growing adoption of advanced diagnostic products, and increasing funding activities, coupled with novel developments in diagnostic technologies, are the factors supporting the largest share of this market.

The key players operating in the IVD quality control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)

Scope of the Report:

IVD Quality Control Market Assessment-by Offering

  • Quality Control Products
    • Quality Control Products, by Type
  • Serum/Plasma-based Controls
  • Whole Blood-based Controls
  • Urine-based Controls
  • Other Controls
    • Quality Control Products, by Function
  • Independent Controls
  • Instrument-Specific Controls
  • Quality Assessment Services
  • Data Management Solutions

Notes: Other controls include saliva-based controls, cerebrospinal fluid-based, and protein controls.

IVD Quality Control Market Assessment-by Technology

  • Immunoassay/Immunochemistry
  • Biochemistry/Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Coagulation/Hemostasis
  • Microbiology
  • Other Technologies

Notes: Other technologies include histochemistry, urinalysis, and whole-blood glucose monitoring

IVD Quality Control Market Assessment-by Application

  • Infectious Diseases
  • Oncology
  • Cardiology
  • Autoimmune Disorders
  • Neurology
  • Other Applications

Notes: Other applications include pregnancy and fertility testing, drug abuse testing, diabetes, genetic disorders, and trace elements testing

IVD Quality Control Market Assessment-by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic Institutes & Research Laboratories
  • Other End Users

Notes: Other end users include home care, nursing homes, ambulatory care centers, and transfusion laboratories.

IVD Quality Control Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Technology Trends
  • 4.4. Regulatory Analysis
    • 4.4.1. Regulations for IVD Products
      • 4.4.1.1. North America
        • 4.4.1.1.1. U.S.
        • 4.4.1.1.2. Canada
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia-Pacific
        • 4.4.1.3.1. China
        • 4.4.1.3.2. Japan
        • 4.4.1.3.3. India
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa
    • 4.4.2. Regulations for Quality Management
      • 4.4.2.1. North America
        • 4.4.2.1.1. U.S.
        • 4.4.2.1.2. Canada
      • 4.4.2.2. Europe
        • 4.4.2.2.1. Germany
        • 4.4.2.2.2. France
        • 4.4.2.2.3. U.K.
        • 4.4.2.2.4. Italy
        • 4.4.2.2.5. Spain
        • 4.4.2.2.6. Rest of Europe (RoE)
      • 4.4.2.3. Asia-Pacific
        • 4.4.2.3.1. China
        • 4.4.2.3.2. Japan
        • 4.4.2.3.3. India
        • 4.4.2.3.4. Rest of Asia-Pacific (RoAPAC)
      • 4.4.2.4. Latin America
      • 4.4.2.5. Middle East & Africa
  • 4.5. Pricing Analysis
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Buyers
    • 4.6.2. Bargaining Power of Suppliers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition
  • 4.7. Associated Market Analysis: In Vitro Diagnostics (IVD) Market

5. IVD Quality Control Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Quality Control Products
    • 5.2.1. Quality Control Products, by Type
      • 5.2.1.1. Serum/Plasma-based Controls
      • 5.2.1.2. Whole Blood-based Controls
      • 5.2.1.3. Urine-based Controls
      • 5.2.1.4. Other Controls
    • 5.2.2. Quality Control Products, by Function
      • 5.2.2.1. Independent Controls
      • 5.2.2.2. Instrument-specific Controls
  • 5.3. Quality Assessment Services
  • 5.4. Data Management Solutions

6. IVD Quality Control Market Assessment-by Technology

  • 6.1. Overview
  • 6.2. Immunoassay/Immunochemistry
  • 6.3. Biochemistry/Clinical Chemistry
  • 6.4. Molecular Diagnostics
  • 6.5. Hematology
  • 6.6. Coagulation/Hemostasis
  • 6.7. Microbiology
  • 6.8. Other Technologies

7. Global IVD Quality Control Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Infectious Diseases
  • 7.3. Oncology
  • 7.4. Cardiology
  • 7.5. Autoimmune Disorders
  • 7.6. Neurology
  • 7.7. Other Applications

8. IVD Quality Control Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Hospitals & Clinics
  • 8.3. Diagnostic Laboratories
  • 8.4. Academic Institutes & Research Laboratories
  • 8.5. Other End Users

9. IVD Quality Control Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies

11. Company Profiles

  • 11.1. Siemens Healthineers AG
    • 11.1.1. Company Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Product Portfolio
    • 11.1.4. SWOT Analysis
  • 11.2. Bio-Rad Laboratories, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Developments
    • 11.2.5. SWOT Analysis
  • 11.3. Danaher Corporation
    • 11.3.1. Company Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Product Portfolio
    • 11.3.4. SWOT Analysis
  • 11.4. LGC Group
    • 11.4.1. Company Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Developments
    • 11.4.5. SWOT Analysis
  • 11.5. Thermo Fisher Scientific Inc.
    • 11.5.1. Business Overview
    • 11.5.2. Financial Overview
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Developments
    • 11.5.5. SWOT Analysis
  • 11.6. Randox Laboratories Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Product Portfolio
    • 11.6.3. Strategic Developments
    • 11.6.4. SWOT Analysis
  • 11.7. SERO AS
    • 11.7.1. Company Overview
    • 11.7.2. Product Portfolio
    • 11.7.3. Strategic Developments
  • 11.8. QuidelOrtho Corporation
    • 11.8.1. Business Overview
    • 11.8.2. Financial Overview
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Developments
  • 11.9. Streck LLC
    • 11.9.1. Company Overview
    • 11.9.2. Product Portfolio
    • 11.9.3. Strategic Developments
  • 11.10. Microbiologics, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Product Portfolio
    • 11.10.3. Strategic Developments
  • 11.11. Bio-Techne Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Overview
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Developments

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports
  • Table 1 A Comparison Between the Characteristics of PBRTQC and Statistical IQC
  • Table 2 Regulatory Authorities Governing IVD Quality Controls, by Country/Region
  • Table 3 IVD Quality Control Product Pricing
  • Table 4 Global IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 5 Global Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 6 Global Quality Control Products Market, by Country/Region, 2021-2030 (USD Million)
  • Table 7 Global Serum/Plasma-Based Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 8 Global Whole Blood-Based Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global Urine-Based Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Global Other Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 12 Global Independent Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Instrument-Specific Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Quality Assessment Services Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Data Management Solutions Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 17 Global IVD Quality Control Market for Immunoassay/Immunochemistry, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global IVD Quality Control Market for Biochemistry/Clinical Chemistry, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global IVD Quality Control Market for Molecular Diagnostics, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global IVD Quality Control Market for Hematology, by Country/Region, 2021-2030 (USD Million)
  • Table 21 Global IVD Quality Control Market for Coagulation/Hemostasis, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global IVD Quality Control Market for Microbiology, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global IVD Quality Control Market for Other Technologies, by Country/Region, 2021-2030 (USD Million)
  • Table 24 Global IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 25 Global IVD Quality Control Market for Infectious Diseases, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Increase in the Number of New Cancer Cases Globally (2020-2040)
  • Table 27 Global IVD Quality Control Market for Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 28 Global IVD Quality Control Market for Cardiology, by Country/Region, 2021-2030 (USD Million)
  • Table 29 Global IVD Quality Control Market for Autoimmune Disorders, by Country/Region, 2021-2030 (USD Million)
  • Table 30 Global IVD Quality Control Market for Neurology, by Country/Region, 2021-2030 (USD Million)
  • Table 31 Global IVD Quality Control Market for Other Applications, by Country/Region, 2021-2030 (USD Million)
  • Table 32 Global IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 33 Global IVD Quality Control Market for Hospitals & Clinics, by Country/Region, 2021-2030 (USD Million)
  • Table 34 Global IVD Quality Control Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 35 Global IVD Quality Control Market for Academic Institutes & Research Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Global IVD Quality Control Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 37 Global IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 38 North America: Estimated Cancer Cases, 2020-2030
  • Table 39 North America: IVD Quality Control Market, by Country, 2021-2030 (USD Million)
  • Table 40 North America: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 41 North America: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 42 North America: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 43 North America: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 44 North America: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 45 North America: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 46 U.S.: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 47 U.S.: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 48 U.S.: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 49 U.S.: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 50 U.S.: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 51 U.S.: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 52 Canada: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 53 Canada: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 54 Canada: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 55 Canada: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 56 Canada: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 57 Canada: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 58 Europe: IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 59 Europe: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 60 Europe: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 61 Europe: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 62 Europe: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 63 Europe: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 64 Europe: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 65 Germany: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 66 Germany: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 67 Germany: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 68 Germany: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 69 Germany: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 70 Germany: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 71 France: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 72 France: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 73 France: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 74 France: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 75 France: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 76 France: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 77 U.K.: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 78 U.K.: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 79 U.K.: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 80 U.K.: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 81 U.K.: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 82 U.K.: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 83 Italy: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 84 Italy: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 85 Italy: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 86 Italy: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 87 Italy: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 88 Italy: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 89 Spain: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 90 Spain: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 91 Spain: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 92 Spain: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 93 Spain: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 94 Spain: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 95 Rest of Europe: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 96 Rest of Europe: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 97 Rest of Europe: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 98 Rest of Europe: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 99 Rest of Europe: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 100 Rest of Europe: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 101 Asia-Pacific: IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 102 Asia-Pacific: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 103 Asia-Pacific: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 104 Asia-Pacific: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 105 Asia-Pacific: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 106 Asia-Pacific: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 107 Asia-Pacific: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 108 China: Mass Testing Drives to Control The Spread of Covid-19 Infections
  • Table 109 China: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 110 China: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 111 China: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 112 China: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 113 China: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 114 China: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 115 Japan: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 116 Japan: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 117 Japan: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 118 Japan: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 119 Japan: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 120 Japan: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 121 India: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 122 India: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 123 India: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 124 India: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 125 India: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 126 India: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 127 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country (2020-2030)
  • Table 128 Rest of Asia-Pacific: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 129 Rest of Asia-Pacific: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 130 Rest of Asia-Pacific: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 131 Rest of Asia-Pacific: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 132 Rest of Asia-Pacific: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 133 Rest of Asia-Pacific: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 134 Latin America: IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 135 Latin America: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 136 Latin America: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 137 Latin America: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 138 Latin America: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 139 Latin America: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 140 Latin America: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 141 Brazil: Testing Initiatives for COVID-19
  • Table 142 Brazil: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 143 Brazil: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 144 Brazil: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 145 Brazil: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 146 Brazil: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 147 Brazil: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 148 Mexico: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 149 Mexico: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 150 Mexico: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 151 Mexico: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 152 Mexico: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 153 Mexico: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 154 Rest of Latin America: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 155 Rest of Latin America: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 156 Rest of Latin America: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 157 Rest of Latin America: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 158 Rest of Latin America: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 159 Rest of Latin America: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 160 Middle East & Africa: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 161 Middle East & Africa: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 162 Middle East & Africa: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 163 Middle East & Africa: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 164 Middle East & Africa: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 165 Middle East & Africa: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 166 Recent Developments, by Company, 2020-2023